Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CT-guided intraganglionic platelet-rich plasma injection for mixed trigeminal neuropathic pain secondary to varicella-zoster virus infection: A case report.

Created on 21 Nov 2026

Authors

YuHui Zheng, Qinghua Yan, Zheng Wang, Rui Pan, Shiyan Wang, RenShu Li

Published in

Medicine. Volume 105. Issue 47. Pages e51545. Nov 20, 2026.

Abstract

Refractory facial pain, particularly when presenting with mixed neuropathic features following varicella-zoster virus (VZV) infection, poses a significant therapeutic challenge. Platelet-rich plasma (PRP) has been preliminarily used for neuropathic pain and postherpetic neuralgia in clinical practice. However, the technical feasibility and procedural details of computed tomography (CT)-guided PRP injection into the trigeminal ganglion remain underreported.
A 55-year-old man presented with recurrent, severe left-sided facial pain characterized by continuous burning dysesthesia superimposed with intermittent paroxysmal electric-shock-like lancinations. He had a history of 2 prior procedures for trigeminal neuralgia (pulsed radiofrequency or radiofrequency thermocoagulation) and a history of varicella (chickenpox) infection one year prior, with subtle erythema in the left V1 dermatome noted on current evaluation.
Mixed trigeminal neuropathic pain secondary to VZV infection.
Under CT guidance, 4 mL of autologous leukocyte-poor PRP (prepared from 16 mL of venous blood) was injected into the ipsilateral trigeminal ganglion via the foramen ovale.
Pain relief began 12 hours post-injection. The visual analog scale (VAS) score decreased from 8 to 9 (at onset) pretreatment to 3 to 4 at 36 hours post-treatment. This therapeutic effect was sustained through the 12-week follow-up period, with a stable VAS score of 2 to 3 and no pain provoked by daily activities. No procedure-related complications occurred.
CT-guided PRP injection into the trigeminal ganglion may be a technically feasible and safe minimally invasive procedure, offering an option for patients who respond poorly to conventional treatments. This case provides the procedural approach and short-term safety data for this method. The effectiveness of this method warrants further validation in larger-scale controlled studies.

PMID:
43063083
Bibliographic data and abstract were imported from PubMed on 21 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement